ImmunityBio Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

San Diego, California--(Newsfile Corp. - March 24, 2026) - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of ImmunityBio, Inc. (NASDAQ: IBRX). The investigation focuses on ImmunityBio executive officers and whether investor losses may be recovered under federal securities laws. What if I purchased ImmunityBio securities?If you purchased ImmunityBio securities and suffered losses on your investment, join our investigation now: Click here to join the investigation.Or for more i ...